Broad-spectrum light versus blue light for phototherapy in neonatal hyperbilirubinemia: a randomized controlled trial. 2015

Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
Department of Neurosciences, Psychology, Drug Research, and Children's Health, University of Florence, Florence, Italy.

Phototherapy is standard care for treatment of neonatal hyperbilirubinemia. Our aim was to compare the effectiveness of broad-spectrum light (BSL) to that of blue light emitting diodes (LED) phototherapy for the treatment of jaundiced late preterm and term infants. Infants with gestational age from 35(+0) to 41(+6) weeks of gestation and nonhemolytic hyperbilirubinemia were randomized to treatment with BSL phototherapy or blue LED phototherapy. A total of 20 infants were included in the blue LED phototherapy group and 20 in the BSL phototherapy group. The duration of phototherapy was lower in the BSL than in the blue LED phototherapy group (15.8 ± 4.9 vs. 20.6 ± 6.0 hours; p = 0.009), and infants in the former group had a lower probability (p = 0.015) of remaining in phototherapy than infants in the latter. We concluded that BSL phototherapy is more effective than blue LED phototherapy for the treatment of hyperbilirubinemia in late preterm and term infants. Our data suggest that these results are not due to the different irradiance of the two phototherapy systems, but probably depend on their different peak light emissions.

UI MeSH Term Description Entries
D007224 Infant Care Care of infants in the home or institution.
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D010789 Phototherapy Treatment of disease by exposure to light, especially by variously concentrated light rays or specific wavelengths. Blue Light Therapy,Blue-light Therapy,Light Therapy,Photoradiation Therapy,Red Light Phototherapy,Therapy, Photoradiation,Blue Light Therapies,Blue-light Therapies,Light Phototherapies, Red,Light Phototherapy, Red,Light Therapies,Light Therapies, Blue,Light Therapy, Blue,Photoradiation Therapies,Phototherapies,Phototherapies, Red Light,Phototherapy, Red Light,Red Light Phototherapies,Therapies, Blue Light,Therapies, Blue-light,Therapies, Light,Therapies, Photoradiation,Therapy, Blue Light,Therapy, Blue-light,Therapy, Light
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D047929 Term Birth CHILDBIRTH at the end of a normal duration of PREGNANCY, between 37 to 40 weeks of gestation or about 280 days from the first day of the mother's last menstrual period. Birth of Full-Term Infant,Birth of Full-Term Newborn,Fullterm Birth,Birth of Full Term Infant,Birth of Full Term Newborn,Birth, Fullterm,Birth, Term,Births, Fullterm,Full-Term Infant Births,Fullterm Births,Term Births
D051556 Hyperbilirubinemia, Neonatal Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) or pathological with toxic levels of bilirubin. Neonatal Hyperbilirubinemia,Direct Hyperbilirubinemia, Neonatal,Hyperbilirubinemia During Infancy,Indirect Hyperbilirubinemia, Neonatal,During Infancies, Hyperbilirubinemia,Hyperbilirubinemia, Neonatal Direct,Hyperbilirubinemia, Neonatal Indirect,Infancy, Hyperbilirubinemia During,Neonatal Direct Hyperbilirubinemia,Neonatal Indirect Hyperbilirubinemia

Related Publications

Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
May 2019, Pediatrics international : official journal of the Japan Pediatric Society,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
February 1985, Pediatrics,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
July 2006, Indian pediatrics,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
January 2019, BioMed research international,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
February 1985, Pediatrics,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
July 1973, The Journal of pediatrics,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
April 1990, Ceskoslovenska pediatrie,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
March 1988, The Journal of pediatrics,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
January 1973, The Journal of pediatrics,
Simone Pratesi, and Sandra Di Fabio, and Cecilia Bresci, and Cecilia Di Natale, and Shahar Bar, and Carlo Dani
July 2012, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Copied contents to your clipboard!